
NOVONESIS B UNSP/ADR by NOVONESIS A S rose 7.1% from $64.02 to $68.58, behind the S&P 500's +10.0%. Its worst day was May 7 (−4.6%), and its low came Mar 19 at $52.81.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
NOVONESIS B UNSP/ADR by NOVONESIS A S shares rose 4.4%, while the S&P 500 rose 0.1%.
+4.4% · S&P 500 +0.1%
EPS of $1.73 was reported on $4.2B revenue (est. $4.9B).
−4.4% · S&P 500 +0.8%
Story events cover the past 12 months · Times ET
NOVONESIS B UNSP/ADR by NOVONESIS A S closed at its lowest level of the year, 17.5% below where the year started.
−0.9% · S&P 500 −0.5%
NOVONESIS B UNSP/ADR by NOVONESIS A S shares fell 4.6%, while the S&P 500 fell 0.3%.
−4.6%, the year's worst day · S&P 500 −0.3%
NOVONESIS B UNSP/ADR by NOVONESIS A S shares rose 5.0%, while the S&P 500 fell 0.3%.
+5.0% · S&P 500 −0.3%
NOVONESIS B UNSP/ADR by NOVONESIS A S shares rose 4.3%, while the S&P 500 fell 0.0%.
+4.3% · S&P 500 0.0%
NOVONESIS B UNSP/ADR by NOVONESIS A S shares rose 4.8%, while the S&P 500 rose 0.2%.
+4.8% · S&P 500 +0.2%
EPS of $1.27 beat the $0.60 estimate on $2.6B revenue (est. $1.3B).
+1.4% · S&P 500 −0.8%
NOVONESIS B UNSP/ADR by NOVONESIS A S closed at its highest level of the year, 12.4% above where the year started.
+0.2% · S&P 500 −0.5%
Where it ended: a close of $68.58 on Nov 9, 2026. Up next: FY 2026 earnings on Feb 24, 2027 (EPS est. $2.45, revenue est. $5.1B).
Nothing in the past 12 months.
All NVZMY analyst actionsNothing in the past 12 months.
All NVZMY dividend history